Australian data dive reveals Real-World use of prostate cancer treatments
NCT ID NCT07223372
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 28 times
Summary
This study looks at prescription records from 1,000 men in Australia with advanced prostate cancer that still responds to hormone therapy. Researchers want to see which drug combinations doctors are actually prescribing and how well patients stick with their treatment. No new treatments are tested—the goal is to learn from real-world data to improve care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONESENSITIVE PROSTATE CANCER (MHSPC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bayer
RECRUITINGPymble, New South Wales, 875, Australia
Conditions
Explore the condition pages connected to this study.